Загрузка...
Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
The development of biological disease-modifying antirheumatic drugs (bDMARDs) and target synthetic DMARDs (tsDMARDs), also known as small molecule inhibitors, represent a breakthrough in rheumatoid arthritis (RA) treatment. The tsDMARDs are a large family of small molecules targeting mostly the seve...
Сохранить в:
| Опубликовано в: : | Cells |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7464410/ https://ncbi.nlm.nih.gov/pubmed/32796683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9081876 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|